>13 years in stem cell and neurodegenerative medicine
Pre-doctoral, doctoral, and post-doctoral research at Drexel, Harvard, Johns Hopkins, and Stanford
Over 15 authored publications in top tier journals, including: Science, Neuron, Nature, and Nature Neuroscience
Cited over 1100 times in peer-reviewed scientific publications
Holds patents on drug development and gene therapy for neurodegenerative disorders
"We believe people with passion can change the world for the better. That's what we believe. And we believe that those people who are crazy enough to think they can change the world are the ones that actually do." Steve Jobs
In the News
"Top 10 Most Influential Leaders in Biotechnology, 2021" release in April, 2021
"30 Admired Companies to Watch, 2021" release in April, 2021
"The 10 Most Innovative Business Leaders Making a Difference in 2021" release in April, 2021
"Possible new drug targets for dementia and intellectual disability" Johns Hopkins Medicine
"Faulty brain circuits repaired using nanotechnology" Science Daily
"RNA Blocked Pathways May Initiate ALS and Dementia" Neuroscience News
"Exercise can ‘clean up’ Alzheimer’s environment" The Harvard Gazette
"RNA Blocked Pathways May Initiate ALS and Dementia" Neuroscience News
"One step closer toward a treatment for Alzheimer's disease?" Science Daily
"Investigating the effects of Norrin on the blood-brain-barrier" American Federation for Aging Research
"Jammed Up Cellular Highways May Initiate Dementia and ALS" Johns Hopkins Medicine
Lavoska Barton is the CEO/President & Co-Founder of PDx.
Lavoska comes with more than 30 years of experience in corporate, nonprofit, educational sectors, and customer-facing leadership positions focused on turnaround operations and business process re-engineering.Lavoska has held executive positions leading $40M+ P&Ls for a number of technology and IT firms. Lavoska founded LBJR Consulting, a consulting firm focused on assisting clients with Strategic Planning and Business Development.
Lavoska has an Executive MBA and BA in Economics from Rockhurst University. He is a Six Sigma Green Belt and has formal quantitative analysis training in forecasting, risk analysis and business case development.
Lavoska considers himself a “servant leader”, placing the interests and needs of his team members ahead of his own self-interests and concerns. Lavoska values their personal development which leads to empowerment and higher levels of productivity.
Very active in community affairs, Lavoska is the Chairman of the Board for Black Men United for Children & Humanity, an organization focused on the needs of children and the “under-represented”. One of his strongest skills is fundraising as he is on the board of the WJW Scholarship committee and has been part of fundraising efforts for the YMCA and Ivy Preparatory Academy.
Lavoska has been a member of Salem Baptist Church in Lilburn GA for a number of years, and has served as Chairman of the Board of Trustees and as a member of the Board of Deacons.
Akash is a Computer science Master's student at Clemson University with a research interest in Deep learning (DL) and machine learning. Akash has done research projects predicting dyslexia based on brain MRI scans, checking the quality of brain MRI scans using CNN, and classifying if the disease is pathogenic based on DNA sequence change. Before these projects, Akash worked as a Software Engineer at Amdocs for 3 years as a team member of DevOps.
While working at PDx, Akash is developing a deep learning model to predict Alzheimer's disease pathogenesis using a huge dataset of patients of different age, sex, and site. This dataset has many different types of data, and all in raw format. Akash is working with the PDx team to build the pipeline to transform and structure the data to train the DL model. With his expertise and experience, Akash is also working to optimize the DL models to achieve higher accuracy.
Akash is a problem solver with a keen interest in research. He enjoys outdoor activities like hiking and loves playing soccer and cricket.
In her decade of experience as a biologist and bioinformatician, Maria has developed a passion for molecular biology and its fundamental importance in medicine, as well as the use of computational tools to explore it.
Her expertise is at the interface of molecular biology, computational biology/bioinformatics, and data science. Maria has previously worked in RNA biology, describing the transcriptomic networks of several stem cell-specific lincRNAs. She led the discovery of a new functional lincRNA responsible for modulating pluripotency pathways in partnership with a novel protein and studied the role of lincRNAs in cell cycle and chromosome architecture modulation.
At PDx, Maria is leveraging the power of multi-omics data to improve diagnostics of neurodegenerative diseases.
Ruchir Bhatt is a medical imaging scientist with a passion for algorithm development. For his PhD in Biomedical Engineering (Florida International University, 2013) he focused on tumor quantification for dose estimations using Positron Emission Tomography (PET). After his doctoral studies, Ruchir joined GE Healthcare Ultrasound as a software engineer for five years where he worked on exciting new research projects including the implementation of new image processing and machine learning algorithms for the evolving field of quantified ultrasound. Working in industry has given him the perspective of regulation and quality required to accelerate cutting-edge research for clinical use. Ruchir’s primary interest is to provide innovative solutions through the development of algorithms for medical imaging. As he has gained more experience and understanding of how research is done in academia and industry, his growing passion is ‘economics of innovation’. He strives to achieve the most innovation out of the available resources as well as improve on current technology.
At PDx, Ruchir is the Lead Scientist on the artificial intelligence and graphics processing project focused on the early diagnosis of Alzheimer’s disease. Ruchir comes with many years of training and is truly an expert in the field.
Dr. Robert Logan comes with many years of expertise and scientific contributions. Robert, is an Assistant Professor of Biology at Eastern Nazarene College (ENC). Robert has accumulated almost a decade of college teaching experience in a wide variety of biological and computational contexts. During this time, Robert held a joint appointment at Harvard Medical School and the Massachusetts General Hospital to conduct Parkinson’s disease research with Dr. Michael Schwarzschild for five years. Robert continues to maintain an active publishing record in high impact journals, publishing as a coauthor at least once every year since 2013. Robert’s research contributions continue at ENC in the pursuit of uncovering telomere dynamics in health and disease by utilizing Third-Generation Sequencing techniques and bioinformatic tools. In his spare time, Robert enjoys listening to music and playing his guitar, spending time at the beach and sailing his boat. Robert is an active member of the First Church of the Nazarene in Lynn, MA and lives in Salem, MA with his family.
At PDx, Dr. Robert Logan will continue to aid the investigations around computational biology and multi-omics for early disease detection.
Federica is the Executive Assistant at PDx Corp.
Federica is originally from Sardinia, Italy before transitioning to the United States to teach and direct a Montessori School (bilingual) in California. Federica speaks five (5) languages and has expertise in communications and management. She performed her formal educational studies in Italy and China.
At PDx, Federica drives forward everyday tasks for the Executive Team.
Chief Scientific Officer, Founder
Chief Executive Officer, Co-Founder Lavoska@PluripotentDiagnostics.com
Machine Learning Scientist